Magnetar Financial’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
E
Magnetar Financial's IBER.U Position: Q3 2022 in Review
Magnetar Financial sold out of Ibere Pharmaceuticals Units (IBER.U) in Q3 2022, closing a stake of 714,500 shares — an estimated $7.05M sold.
Magnetar Financial first reported a position in IBER.U in Q1 2021 and held it in 6 quarters. The position peaked at $8.07M in Q2 2021. 13 funds tracked by Wall St. Rank hold IBER.U as of Q3 2022.
- Magnetar Financial reported no remaining Ibere Pharmaceuticals Units position as of Q3 2022 after selling out during the quarter.
- Magnetar Financial sold 714,500 Ibere Pharmaceuticals Units shares in Q3 2022, an estimated $7.05M.
- Magnetar Financial first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 6 quarters.
- Magnetar Financial's Ibere Pharmaceuticals Units position peaked at $8.07M in Q2 2021.
- 13 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q3 2022.
Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.